Advisors Preferred’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,386
Closed -$140K 236
2024
Q3
$140K Buy
+2,386
New +$136K 0.02% 162
2023
Q2
Sell
-422
Closed -$22.7K 207
2023
Q1
$22.7K Buy
+422
New +$22.5K 0.01% 142
2020
Q4
Sell
-132
Closed -$7K 182
2020
Q3
$7K Buy
+132
New +$6.39K ﹤0.01% 137
2019
Q2
Sell
-6,606
Closed -$255K 245
2019
Q1
$255K Buy
+6,606
New +$240K 0.08% 90
2018
Q4
Sell
-4,488
Closed -$170K 166
2018
Q3
$170K Buy
+4,488
New +$159K 0.08% 91
2017
Q3
Sell
-6,732
Closed -$187K 247
2017
Q2
$187K Sell
6,732
-6,648
-50% -$176K 0.1% 80
2017
Q1
$338K Buy
+13,380
New +$324K 0.18% 51
2016
Q1
Sell
-8,628
Closed -$176K 231
2015
Q4
$176K Buy
8,628
+6,672
+341% +$134K 0.1% 59
2015
Q3
$36K Buy
+1,956
New +$39.3K 0.04% 79
2015
Q1
Sell
-16,836
Closed -$317K 304
2014
Q4
$317K Buy
+16,836
New +$304K 0.15% 99
2014
Q3
Sell
-2,352
Closed -$40K 284
2014
Q2
$40K Sell
2,352
-12,378
-84% -$202K 0.02% 177
2014
Q1
$243K Buy
14,730
+9,024
+158% +$145K 0.11% 132
2013
Q4
$88K Buy
+5,706
New +$85.1K 0.05% 158

Other funds holding IHI

Advisors Preferred's IHI Position: Q4 2024 in Review

Advisors Preferred sold out of iShares US Medical Devices ETF (IHI) in Q4 2024, closing a stake of 2,386 shares — an estimated $140K sold.

Advisors Preferred first reported a position in IHI in Q4 2013 and held it in 13 quarters. The position peaked at $338K in Q1 2017. 566 funds tracked by Wall St. Rank hold IHI as of Q4 2024.

  • Advisors Preferred reported no remaining iShares US Medical Devices ETF position as of Q4 2024 after selling out during the quarter.
  • Advisors Preferred sold 2,386 iShares US Medical Devices ETF shares in Q4 2024, an estimated $140K.
  • Advisors Preferred first reported a position in iShares US Medical Devices ETF in Q4 2013 and held it in 13 quarters.
  • Advisors Preferred's iShares US Medical Devices ETF position peaked at $338K in Q1 2017.
  • 566 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2024.

Based on Advisors Preferred's 13F filing for Q4 2024, filed 28 Jan 2025.